Live

BioPharma DivecAMPfield lands $180M to build gut disease drug Endpoints NewsNovo Nordisk expands in China and Czech; Cellares boosts Series D by $50M BioPharma DiveBiogen adds more immune drugs in $1B buyout of secretive startup Raythera Promega BlogWhat Happens When You Delay an Ebola Vaccine Booster by 18 Months?FierceBiotechcAMPfield harvests $180M series A to advance oral IBD drug licensed from Newsoara Endpoints NewsIRA's Medicare out-of-pocket cap increased access to drugs, study finds Endpoints NewsPrepping for peptides BioPharma DivePfizer CFO to step down; Denali sells a regulatory fast-pass Endpoints NewsPfizer CFO to depart; GSK wins approval for UTI drug Endpoints NewsRA, Forbion and Sanofi Ventures appear to back new eye drug from Korea Endpoints NewsNovocure’s electric fields therapy fails key glioblastoma study BioWorldShanghai Pharmaceuticals discovers new IL-17A inhibitors

Promega Blog Jun 18, 2026

What Happens When You Delay an Ebola Vaccine Booster by 18 Months?

Ebola Virus Disease (EBOD) remains one of the most severe viral infections, with case fatality rates reaching 40% during the 2013-2016 West African outbreak tha...

Ebola Virus Disease (EBOD) remains one of the most severe viral infections, with case fatality rates reaching 40% during the 2013-2016 West African outbreak that claimed over 11,000 lives (1). At this scale, durable protection isn’t optional. If you’ve followed vaccine development, you’ve probably noticed something counterintuitive. Shorter intervals between doses are not always better. […] The post What Happens When You Delay an Ebola Vaccine Booster by 18 Months? appeared first on Promega Connections .